Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 240 articles:
HTML format
Text format



Single Articles


    May 2017
  1. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    PubMed     Text format     Abstract available


  2. REGUEIRO A, Granada JF, Dagenais F, Rodes-Cabau J, et al
    Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges.
    J Am Coll Cardiol. 2017;69:2175-2192.
    PubMed     Text format     Abstract available


    April 2017
  3. KIM EK, Park TK, Yang JH, Song YB, et al
    Ticagrelor Versus Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:2098-2099.
    PubMed     Text format    


  4. PALMERINI T, Bacchi Reggiani L, Della Riva D, Romanello M, et al
    Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.
    J Am Coll Cardiol. 2017;69:2011-2022.
    PubMed     Text format     Abstract available


  5. JAKOVLJEVIC DG, Yacoub MH, Schueler S, MacGowan GA, et al
    Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1924-1933.
    PubMed     Text format     Abstract available


  6. HOEDEMAKER NP, Damman P, Woudstra P, Hirsch A, et al
    Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
    J Am Coll Cardiol. 2017;69:1883-1893.
    PubMed     Text format     Abstract available


    March 2017
  7. HANNAN EL, Samadashvili Z, Cozzens K, Gesten F, et al
    Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    J Am Coll Cardiol. 2017;69:1234-1242.
    PubMed     Text format     Abstract available


  8. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association f
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)30385.
    PubMed     Text format    


  9. JESSUP M, Drazner MH, Book W, Cleveland JC Jr, et al
    2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac T
    J Am Coll Cardiol. 2017 Mar 3. pii: S0735-1097(17)30791.
    PubMed     Text format    


    February 2017
  10. ZHAO DF, Edelman JJ, Seco M, Bannon PG, et al
    Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.
    J Am Coll Cardiol. 2017;69:924-936.
    PubMed     Text format     Abstract available


  11. MASHAYEKHI K, Neuser H, Kraus A, Zimmer M, et al
    Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total Occlusions.
    J Am Coll Cardiol. 2017;69:1095-1096.
    PubMed     Text format    


  12. LEE PH, Park DW, Park SJ
    Reply: The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:756-757.
    PubMed     Text format    


  13. COLOMBO A, Ancona MB, Chieffo A
    The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:755-756.
    PubMed     Text format    


  14. GALLOE AM, Kelbaek H, Thuesen L, Hansen HS, et al
    10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.
    J Am Coll Cardiol. 2017;69:616-624.
    PubMed     Text format     Abstract available


    January 2017
  15. ROLLINI F, Franchi F, Angiolillo DJ
    Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:250-251.
    PubMed     Text format    


  16. KIM WY
    Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:249-250.
    PubMed     Text format    


  17. VADUGANATHAN M, Harrington RA, Stone GW, Deliargyris EN, et al
    Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:176-185.
    PubMed     Text format     Abstract available


  18. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Reply: Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:117-118.
    PubMed     Text format    


  19. FERNANDEZ-PEREIRA C, Mieres J, Rodriguez AE
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:116-117.
    PubMed     Text format    


  20. POURDJABBAR A, Hibbert B, Patel MP, Reeves RR, et al
    Incomplete Revascularization: The Achilles Heel of Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2017;69:115-116.
    PubMed     Text format    


    December 2016
  21. MULLER DW, Farivar RS, Jansz P, Bae R, et al
    Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37122.
    PubMed     Text format     Abstract available


  22. HERRMANN HC, Chitwood WR Jr
    Transcatheter Mitral Valve Replacement Clears the First Hurdle.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37121.
    PubMed     Text format    


  23. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Th
    J Am Coll Cardiol. 2016 Dec 14. pii: S0735-1097(16)36782.
    PubMed     Text format    


    November 2016
  24. NDREPEPA G, Colleran R, Braun S, Cassese S, et al
    High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:2259-2268.
    PubMed     Text format     Abstract available


  25. ROSS RD, Srivastava S, Cabrera AG, Ruch-Ross HS, et al
    The United States Pediatric Cardiology 2015 Workforce Assessment: A Survey of Current Training and Employment Patterns: A Report of the American College of Cardiology, American Heart Association, American Academy of Pediatrics Section on Cardiology an
    J Am Coll Cardiol. 2016 Nov 21. pii: S0735-1097(16)36323.
    PubMed     Text format    


  26. KUMAR A, Wagener J, Jones S, Wojdyla D, et al
    TCT-244 Lower rates of repeat revascularization among patients with prior coronary artery bypass grafting is partly due to lack of adequate target vessels.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  27. CHO MS, Do U, Lee K, Hong JA, et al
    TCT-242 Temporal Changes in Outcomes after Stent or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease by Diabetes Status.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  28. KARACSONYI J, Martinez-Parachini JR, Alame A, Danek BA, et al
    TCT-233 Contemporary Use of Laser during Percutaneous Coronary Intervention: Initial Results from the Laser Veterans Affairs (LAVA) Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  29. EDES IF, Ruzsa Z, Szabo G, Lux A, et al
    TCT-228 Rotational atherectomy of malapposed, undilatable coronary stents: fact or fiction?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  30. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  31. HWANG D, Lee JM, Rhee TM, Park J, et al
    TCT-222 Clinical Outcomes of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease: Patient-level Meta-analysis of 4 Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  32. FARHAN S, Baber U, Chandrasekhar J, Sartori S, et al
    TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  33. FAGGIONI M, Chandrasekhar J, Baber U, Vogel B, et al
    TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  34. MAHMOUD A, Elgendy I
    TCT-218 Factors influencing the risk of major bleeding with bivalirudin compared with unfractionated heparin in percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  35. MAHMOUD A, Elgendy I
    TCT-215 Meta-analysis of randomized trials comparing bivalirudin versus unfractionated heparin for percutaneous coronary intervention through trans-radial approach.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  36. LAU J, Alcock R, Cherry J, Yong A, et al
    TCT-212 Application of the DAPT score to a contemporary Percutaneous Coronary Intervention cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  37. GIUSTINO G, Chieffo A, Palmerini T, Valgimigli M, et al
    TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  38. SAAD M, Gamal A, Nairooz R
    TCT-210 Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  39. HARADA Y, Lohaus R, Mayer K, Emmer R, et al
    TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  40. PHILIP F, Anderson S, Ram S, Bommer W, et al
    TCT-202 Interaction between choice of anticoagulation, antiplatelet therapy and access site on mortality and bleeding after percutaneous coronary intervention: Insights from the California NCDR registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  41. SHIN H, Jang JS, Jin HY, Seo JS, et al
    TCT-192 Combined Use of Neutrophil to Lymphocyte Ratio and C-Reactive Protein to predict Clinical Outcomes in Acute Myocardial Infarction Patients undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  42. MAHMOUD A, Elgendy A, Mansoor H, Mojadidi M, et al
    TCT-191 Intravenous beta-blockers for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  43. BAEK JY, Rha SW, Choi BG, Byun JK, et al
    TCT-189 Comparison of 5-year Clinical Outcomes between Stabilized Acute Myocardial Infarction Patients following Percutaneous Coronary Intervention and the Patients with Angina Pectoris.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  44. ELIAS J, van Dongen I, Hoebers L, Ouweneel D, et al
    TCT-188 The impact of the location on left ventricular function in ST-elevation Myocardial Infarction patients with a chronic total occlusion in a non-infarct related artery treated with percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  45. ROBERTS L, Parfrey S, Andrianopoulos N, Teh A, et al
    TCT-187 Safety of Early Discharge Following Percutaneous Coronary Intervention (PCI) for STEMI.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  46. JANG JH, Kim DK, Song PS, Kim DI, et al
    TCT-185 Influence of total ischemic time on clinical outcomes and efficacy of manual thrombus aspiration during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Analysis from the POST trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  47. GIUSTINO G, Mehran R, Kirtane A, Redfors B, et al
    TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  48. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  49. HAHN JY, Kim EK, Park TK, Lee JM, et al
    TCT-171 Effect of Ticagrelor Compared with Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  50. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  51. SAIB A, Payot L, Kerneis M, Barthelemy O, et al
    TCT-160 Impact of admission during ON vs. OFF hours in unselected ST-Elevation Myocardial Infarction Patients treated with Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  52. NARAYANAN MA, Reddy YN, Anugula D, Gujjula N, et al
    TCT-156 Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  53. SONG Y, Ma YL, Zhang JH, Tang XF, et al
    TCT-155 Prognostic Impact of the Residual SYNTAX Score on 2-years Outcomes in Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  54. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  55. CID ALVAREZ AB, Redondo Dieguez A, Galvao Braga C, Trillo R, et al
    TCT-149 Impact of Chronic Total Occlusion in a Non-Infarct-related Artery on clinical outcomes in patients undergoing Primary Percutanous Coronary Intervention: analysis of a 8 year-all-comers prospective registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  56. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  57. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-13 Outcomes of chronic total occlusion percutaneous coronary intervention according to dissection/re-entry versus wire escalation techniques.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  58. JONES D, Rathod K, Weerackody R, Wragg A, et al
    TCT-14 Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes after CTO Percutaneous Coronary Interventions: An observational study of 5,496 patients from the Pan-London CTO Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  59. DANEK BA, Karatasakis A, Karmpaliotis D, Alaswad K, et al
    TCT-15 Use of Antegrade Dissection Re-entry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  60. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-144 Impact of Thrombus Aspiration in Primary Percutaneous Coronary Intervention On Long-Term Outcome.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  61. VOUDRIS K, Vidovich M
    TCT-142 Temporal Trends in Incidence of Acute Myocardiacl Infarction in Patients With Malignancy Undergoing Percutaneous Coronary Intervention (PCI).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  62. VOUDRIS K, Vidovich M
    TCT-143 Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in patients with history of Malignancy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  63. VOUDRIS K, Vidovich M
    TCT-141 Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in patients with Systemic lupus erythematosus: analysis from Nationwide Inpatient Sample (NIS).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  64. HAMZA M, Elgendy I
    TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  65. CID ALVAREZ AB, Galvao Braga C, Redondo Dieguez A, Trillo R, et al
    TCT-138 Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation myocardial infarction: analysis of a 8 year-all-comers registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  66. SHAVELLE D, Kapasi N, Banerjee S, Schreiber T, et al
    TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  67. SHARMA S, Palacios I, O'Neill W, Witzke CF, et al
    TCT-124 Predictors of the Need for Continuous Impella Support in High Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  68. FLAHERTY M, Pant S, Kilgore T, Dassanayaka S, et al
    TCT-123 Impella 2.5 Support Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  69. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  70. RATHOD K, Mathur A, Wragg A, O'Mahony C, et al
    TCT-117 Impact of Intra-aortic Balloon Pump use on mortality in patients with cardiogenic shock treated with Primary Percutaneous Coronary Intervention: An Observational Study of 21,210 patients with ST-Elevation Myocardial Infarction from the London
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  71. ANSARI M, Garcia D
    TCT-116 Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis of RCT's.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  72. CHANDRASEKHAR J, Baber U, Sartori S, Aquino M, et al
    TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  73. GARCIA E, Hong S, Cho SA, Cho JY, et al
    TCT-108 Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective,
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  74. SHAH R, Hwang IH, Nayyar M, Christian E, et al
    TCT-102 Association Between Operator Experience with Access Type in Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome: A Network Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  75. LACOMBE A, O'Brien A, Bundy J, Clarey A, et al
    TCT-852 Impact of Robotics and a Suspended Lead Suit on Physician Radiation Exposure During Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  76. YADAV P, Wang DD, Eng M, Greenbaum A, et al
    TCT-813 Alcohol Septal Ablation in patients with Left Ventricular Outflow Tract Obstruction after Transcatheter Mitral Valve Replacement for Mitral Annular Calcification (TMVR in MAC).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  77. YOON HJ, Oh JH, Kim KB, Bae HJ, et al
    TCT-76 Temporal change of in-stent thrombus immediately after percutaneous coronary intervention within 5 minutes using optical coherence tomography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  78. VOUDRIS K, Devereux R, Feldman D, Minutello R, et al
    TCT-745 In-Hospital Clinical Outcomes Post Transcatheter Aortic Valve Replacement (TAVR) in Patients with History of Non-Cardiac Transplantation: Insights from the National Inpatient Sample (NIS) Database.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  79. CHETCUTI S, Kleiman N, Matthews R, Popma J, et al
    TCT-743 Percutaneous Coronary Intervention after Self-Expanding Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  80. SMITS P, Ben-Yehuda O, Kosmidou I, Ozan MO, et al
    TCT-71 The NIREUS Randomized Trial: 1-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) EUropean Angiography Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  81. WONG SC, Voudris K, Bergman G, Minutello R, et al
    TCT-709 Trans-apical Transcatheter Aortic Valve Replacement in Patients with History of Coronary Artery Bypass Grafting: An Analysis from the National Inpatient Sample Database.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  82. SINGH V, Thakkar B, Rodriguez A, Patel N, et al
    TCT-697 Comparison of Outcomes of Transcatheter Aortic Valve Replacement plus Percutaneous Coronary Intervention versus Transcatheter Aortic Valve Replacement Alone in the United States.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  83. PATEL N, Patel N, Arora S, Singh V, et al
    TCT-680 Impact of Annual Hospital Percutaneous Coronary Intervention Volume on Transcatheter Aortic-Valve Replacement Outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  84. CHANDRASEKHAR J, Redfors B, Genereux P, Kirtane A, et al
    TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  85. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-64 Percutaneous coronary intervention for in-stent chronic total occlusion: procedural and long-term outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  86. ISHIHARA S, Muramatsu T, Kashima Y, Okamura A, et al
    TCT-62 Outcomes of re-attempt percutaneous coronary intervention for chronic total occlusion: 2-year data from Retrograde Summit Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  87. SERRUYS P, Guidotti A, Abdelghani M, Miyazaki Y, et al
    TCT-637 The transapical AccuFit bioprosthesis for transcatheter mitral valve replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  88. WANG DD, Eng M, Greenbaum A, Guerrero M, et al
    TCT-626 Validating a prediction modeling tool for LVOT obstruction after transcatheter mitral valve replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  89. MASHAYEKHI K, Toma A, Behnes M, Gick M, et al
    TCT-61 Long-term Outcomes of Patients with Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  90. OTA H, Tanigaki T, Okamoto S, Omori H, et al
    TCT-593 The Impact of Coronary Plaque Composition on Fractional Flow Reserve Improvement after Percutaneous Coronary Intervention: An Integrated-backscatter Intravascular Ultrasound Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  91. HASHIMOTO S, Takahashi A, Yamada T, Mizuguchi Y, et al
    TCT-589 Effectiveness of Excimer Laser Coronary Angioplasty with Optical Coherence Tomography Guidance for In-stent Restenosis after Drug Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  92. VERMA K, Cheshire C, Nerlekar N, McCormick L, et al
    TCT-577 Intravascular ultrasound guidance during percutaneous coronary intervention using second-generation drug-eluting stents improves clinical outcomes and reduces restenosis rates: a comparative 8,265 patient meta-analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  93. KARACSONYI J, Alaswad K, Jaffer F, Yeh R, et al
    TCT-572 Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  94. SAITO Y, Kitahara H, Nakayama T, Fujimoto Y, et al
    TCT-560 Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  95. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-559 Optical coherence tomography (OCT) guided percutaneous coronary intervention : clinical impact of acute abnormal findings after drug-eluting stent implantation detected only by OCT.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  96. OH JH, Choe JC, Ahn J, Sup PJ, et al
    TCT-558 Comparison of in-hospital outcome between intracoronary imaging-guided versus angiography-guided percutaneous coronary intervention in patient with acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  97. TANG Y, Tian J, Guan C, Wang W, et al
    TCT-555 Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  98. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    TCT-549 ROLE of RESIDUAL ACUTE STENT MALAPPOSITION in percutaneous coronary interventions: a CLI-OPCI project SUBSTUDY.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  99. ALI Z, Galougahi KK, Nazif T, Maehara A, et al
    TCT-546 Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  100. VAN BOMMEL R, Lemmert M, Wang Y, Daemen J, et al
    TCT-536 Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention with a Novel FFR Micro Catheter, Insights from the FFR-SEARCH Registry - FFR Stent Evaluated at Rotterdam Cardiology Hospital.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  101. WOLNY R, Pregowski J, Kruk M, Kepka C, et al
    TCT-507 Computed Tomography Angiography Versus Angiography for Guiding Percutaneous Coronary Interventions in Bifurcation Lesions - Prospective Randomized Pilot Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  102. PLEWKA M, Peruga J, Peruga J, Tondo C, et al
    TCT-501 Ultrasound examination of the forearm arteries morphology and anomalies in patients undergoing percutaneous coronary intervention via radial access.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  103. EBRAHIMI R, Mehran R, Ben-Yehuda O, Parvataneni R, et al
    TCT-5 Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights from the ACUITY trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  104. THEODOROPOULOS K, Meelu O, Mennuni M, Sartori S, et al
    TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing pe
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  105. HARADA Y, Colleran R, Kufner S, Giacoppo D, et al
    TCT-483 Angiographic and two-year clinical outcomes following percutaneous coronary intervention for in-stent restenosis of polymer-free sirolimus- and probucol-eluting stent compared with durable polymer zotarolimus-eluting stent.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  106. DURGAPRASAD R, Vanajakshamma V, Vamsidhar A, Kasala L, et al
    TCT-485 A study of safety and efficacy of biodegradable polymer coated Everolimus-eluting coronary stent system [Everoflex] at intermediate follow-up in real world scenario.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  107. GIUSTINO G, Melegari C, Baber U, Sartori S, et al
    TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  108. HAN Y, Yang Y, Fu G, Su XI, et al
    TCT-473 A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  109. VERHEYE S, Abizaid A, Botelho R, Costa R, et al
    TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne(R) Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  110. KAUL U, Abhaichand DR, Patel T, Banker D, et al
    TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  111. VERHEYE S, Stella P, Carrie D, Khattab A, et al
    TCT-456 Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  112. GIUSTINO G, Baber U, Sartori S, Stone G, et al
    TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  113. TORII S, Kolodgie F, Cheng D, Acampado E, et al
    TCT-446 Fluoropassivation of Coronary Stents as a Potential Mechanism of Improved Thromboresistance.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  114. LEE SY, Torguson R, Garcia-Garcia HM, Tang G, et al
    TCT-445 Does the Risk of Bleeding Impacts Selection of Stent Type during Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  115. KIM DK, Jang JH, Song YS, Seo GW, et al
    TCT-442 3-year clinical outcomes of complete versus partial stent fracture after percutaneous coronary intervention with second-generation drug-eluting stent.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  116. NEF H, Hauptmann KE, Latib A, Morrison L, et al
    TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve(R) Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  117. KARAMASIS G, Al-Janabi F, Mohdnazri S, Jagathesan R, et al
    TCT-386 Incidence and prevention of contrast induced acute kidney injury in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  118. TANG G, Garcia-Garcia HM, Rogers T, Kiramijyan S, et al
    TCT-374 Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  119. VITELA J, Diaz VJ, Hernandez E, Juan-Salvadores P, et al
    TCT-371 Anatomical complications and difficulties of the radial and ulnar access for percutaneous coronary interventions: analysis in more than 10, 000 patients.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  120. PIQUERAS-FLORES J, Sanchez-Perez I, Jurado A, Lopez Lluva MT, et al
    TCT-350 Clinical Results At A Long-Term Follow-Up Of Percutaneous Coronary Intervention In Left Main Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  121. BLACHUT A, Pruski M Jr, Trendel W, Janas A, et al
    TCT-348 Long term outcomes of same-day discharged patient after percutaneous coronary intervention in stand-alone centers.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  122. DO U, Kwon O, Lee K, Hong JA, et al
    TCT-344 Impact of Body Mass Index on the Clinical outcomes of patients with Angiographic High-risk Coronary Artery Disease underwent Percutaneous Coronary Intervention: data from the Asan multi-vessel registry and IRISMAIN registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  123. JIANG L, Yuan J, Gao R, Xu B, et al
    TCT-346 Impact of anemia after coronary stenting on long-term outcomes of patients with coronary disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  124. FEDELE S, Abdul FB, Ossei-Gerning N, Choudhury A, et al
    TCT-342 Incomplete Revascularisation and 12-month Mortality in Octogenarians Undergoing Percutaneous Coronary Intervention: Support for a Conservative DES-Driven Strategy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  125. FUNG RC, Norris C, Galbraith D, Southern D, et al
    TCT-341 Unplanned Nontarget Lesion Revascularizations after Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  126. JANG WJ, Yang JH, Choi SH, Hahn JY, et al
    TCT-338 Clinical Implications of the Residual SYNTAX Score after Percutaneous Coronary Intervention in patients with Chronic Total Occlusion and Multi-vessel Coronary Artery Disease: A Comparison with Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  127. HARADA Y, Michel J, Koenig W, Rheude T, et al
    TCT-337 Prognostic value of high-sensitivity cardiac troponin T and gender differences in patients undergoing elective percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  128. DANSON E, Sapontis J, Dworakowski R, Webb I, et al
    TCT-336 Percutaneous coronary revascularization versus medical therapy in a surgically ineligible cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  129. SAWANT A, Singh V, Josey K, Plomondon M, et al
    TCT-334 Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: A National Veterans Affairs Database Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  130. COCKBURN J, Hildick-Smith D, Curzen N, Ludman P, et al
    TCT-333 Percutaneous Coronary Intervention in Octogenarians: A Risk Scoring System to Predict Outcomes in the Elderly On behalf of the British Cardiovascular Intervention Society (BCIS), and the National Institute for Cardiovascular Outcomes Research
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  131. DOMINGUEZ SC, Quero MF, Rangel-Sousa D, Cubero JM, et al
    TCT-328 Coronary stenting in cardiac allograft vasculopathy: A single center experience.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  132. PARK DW, Kang SH, Choi H, Ahn JM, et al
    TCT-327 Prevalence, Management, and Outcomes of Atrial Fibrillation Among Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  133. JANG JH, Kim DK, Song PS, Kim DI, et al
    TCT-326 Major predictors of long-term clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesions with 2-stent strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  134. VACCARO V, Bossi IM, D'Anna M, Piccalo G, et al
    TCT-323 Predictors of clinical outcome and subsequent target lesion revascularization after percutaneous coronary procedures with drug eluting stents and everolimus eluting bioresorbable scaffolds for cardiac allograft vasculopathy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  135. MILOJEVIC M, Head S, Mack M, Mohr F, et al
    TCT-314 The impact of chronic kidney disease on outcomes following percutaneous coronary interventions versus coronary artery bypass grafting in patients with complex coronary artery disease: 5-year follow-up of the SYNTAX trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  136. JATENE T, Biering-Sorensen T, Nochioka K, Mangione F, et al
    TCT-312 Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An analysis of the BASKET-PROVE I and II trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  137. CHO MS, Kang DY, Do U, Hong JA, et al
    TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  138. GUTIERREZ-BARRIOS A, Canada D, Diaz-Retamino E, Ruiz D, et al
    TCT-309 CLINICAL IMPACT OF CHRONIC TOTAL OCCLUSIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION OF UNPROTECTED LEFT MAIN DISEASE.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  139. RESENDES E, Karmpaliotis D, Alaswad K, Jaffer F, et al
    TCT-308 Impact of Race and Ethnicity on Technical and In-Hospital Outcomes Following Chronic Total Occlusions Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  140. BENINCASA S, Azzalini L, Bellini B, Carlino M, et al
    TCT-304 Outcomes of the retrograde approach through epicardial versus non-epicardial collaterals in chronic total occlusion percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  141. QINTAR M, Sapontis J, Grantham JA, Lombardi W, et al
    TCT-300 Dyspnea Among Patients with Chronic Total Occlusions Selected for Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  142. ALAME A, Karmpaliotis D, Alaswad K, Jaffer F, et al
    TCT-301 Outcomes of Percutaneous Coronary Intervention in Chronic Total Occlusions Caused by In-Stent Restenosis: Insights from a U.S. Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  143. KANMANTHAREDDY A, Koduri H, Balmuri A, Anugula D, et al
    TCT-299 Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusions: Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  144. BALMURI A, Kanmanthareddy A, Anugula D, Gujjula N, et al
    TCT-298 Successful Versus Unsuccessful Percutaneous Coronary Intervention of Chronic Total Occlusions: A Contemporary Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  145. GALASSI A, Boukhris M, Belhadj Z, Laaroussi L, et al
    TCT-297 Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients with Low Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  146. LEE SY, Bernardo N, Robert A G, Garcia-Garcia HM, et al
    TCT-295 Percutaneous Coronary Intervention in Chronic Total Occlusions: A Single Center Experience on the Impact and Efficacy of Using Contemporary Techniques.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  147. SANCHEZ-PEREZ I, Piqueras-Flores J, Jurado A, Lopez Lluva MT, et al
    TCT-293 High Syntax score and left main percutaneous coronary intervention in high risk patients. Results at a 10 year follow-up.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  148. KARATASAKIS A, Danek BA, Karmpaliotis D, Alaswad K, et al
    TCT-289 Comparison of Various Scores for Predicting Success and Efficiency of Chronic Total Occlusion Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  149. PATEL S, Menon R, Burke MN, Jaffer FA, et al
    TCT-287 Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  150. GIUSTINO G, Baber U, Genereux P, Stone G, et al
    TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  151. SANCHEZ-PEREZ I, Piqueras-Flores J, Lozano F, Lopez Lluva MT, et al
    TCT-285 Ten year follow-up results of left main percutaneous coronary intervention in elderly patients.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  152. RHA SW, Choi SY, Choi BG, Byun JK, et al
    TCT-283 Impact of Successful Percutaneous Coronary Intervention on Chronic Total Occlusion Outcomes in Patients with Well-developed Coronary Collateral Flow.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  153. RILEY R, Sapontis J, Jones P, Kirtane A, et al
    TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  154. DANEK BA, Karatasakis A, Karmpaliotis D, Alaswad K, et al
    TCT-281 Development and Validation of a Scoring System for Predicting Major Adverse Cardiovascular Events during Percutaneous Coronary Interventions of Chronic Total Occlusions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic To
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  155. SHIN H, Jang JS, Jin HY, Seo JS, et al
    TCT-279 Impact of Successful Recanalization of Chronic Total Occlusions using Coronary Stents on Long-Term Clinical Outcomes: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  156. KARATASAKIS A, Danek BA, Karmpaliotis D, Alaswad K, et al
    TCT-278 Application and Outcomes of the Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: an Update from a Contemporary Multicenter US Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  157. HUANG CC, Sasaki Y, Meng SW, Hokama Y, et al
    TCT-274 Size And Tortuosity of A Collateral Channel Are Important Predictors of Successful Tracking in Retrograde Percutaneous Coronary Intervention (PCI) For Chronic Total Occlusion (CTO).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  158. PANCHAL H, Zheng S, Abusara A, Mogusu E, et al
    TCT-272 National Trend in Hospitalization Cost for In-patient Single Vessel Percutaneous Coronary Intervention in Patients with and without Diabetes Mellitus in the United States: An Analysis from Nationwide Inpatient Sample from 2006-2011.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  159. CHOI KH, Choi JH, Yang JH, Choi SH, et al
    TCT-270 Long-term clinical outcomes of patients with coronary chronic total occlusion treated with percutaneous coronary intervention versus medical therapy according to presence of diabetes mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  160. VOGEL B, Baber U, Sartori S, Chandrasekhar J, et al
    TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  161. LEE SY, Garcia-Garcia HM, Kuku K, Azizi V, et al
    TCT-269 Impact of Incomplete Revascularization in Diabetes Mellitus Patients with Multivessel Disease Treated with Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  162. VOGEL B, Baber U, Chandrasekhar J, Aquino M, et al
    TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  163. XU B, Murphy J, Yang Y, Qiao S, et al
    TCT-263 Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  164. GUTTMANN O, Jones D, Gulati A, Crake T, et al
    TCT-259 Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  165. CHO MS, Kang DY, Do U, Hong JA, et al
    TCT-258 Clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention for multi-vessel coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  166. HE Y, Li Y, Zhang D, Xu B, et al
    TCT-254 A Novel Tool for Risk Prediction of PEriprocedural MyocaRdial InFarction after PErcutaneous Coronary InTervention: the PERFECT Score System.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  167. KINNAIRD T, Kwok CS, Kontopantelis E, Nick OG, et al
    TCT-252 The incidence, determinants and outcomes of coronary perforation during percutaneous coronary intervention in the United Kingdom between 2006-2013: an analysis of 527,121 cases from the British Cardiovascular Intervention Society database.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  168. PAPAPOSTOLOU S, Andrianopoulos N, Brennan A, Ajani A, et al
    TCT-250 Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  169. PATEL G, Kher A, Nanavaty S, Patel T, et al
    TCT-251 Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  170. ROSSI J, Stearns S, Vavalle J, Caranasos T, et al
    TCT-247 Discharge Status Following Coronary Artery Bypass or Percutaneous Coronary Intervention from the National Inpatient Sample.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  171. THUESEN AL, Riber L, Mortensen PE, Irmukhamedov A, et al
    TCT-245 Association of intraoperative transit time flow after grafting and invasive coronary flow and pressure measurements before coronary artery bypass surgery.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  172. OUWENEEL DM, Eriksen E, Seyfarth M, Henriques JP, et al
    Impella Versus Intra-Aortic Balloon Pump For Treatment Of Cardiogenic Shock: A Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36771.
    PubMed     Text format    


  173. OUWENEEL DM, Eriksen E, Sjauw KD, van Dongen IM, et al
    Impella CP Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The IMPRESS trial.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36767.
    PubMed     Text format     Abstract available


  174. WELSH RC, Peterson ED
    Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Complex Decision or Not?
    J Am Coll Cardiol. 2016;68:1865-1867.
    PubMed     Text format    


  175. CAPRETTI G, Urena M, Himbert D, Brochet E, et al
    Valve Thrombosis After Transcatheter Mitral Valve Replacement.
    J Am Coll Cardiol. 2016;68:1814-1815.
    PubMed     Text format    


  176. BRILAKIS ES, Abdullah SM, Banerjee S
    Who Should Undergo Chronic Total Occlusion Percutaneous Coronary Intervention?: The EXPLORation Continues.
    J Am Coll Cardiol. 2016;68:1633-1636.
    PubMed     Text format    


    September 2016
  177. CAVALCANTE R, Sotomi Y, Lee CW, Ahn JM, et al
    Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.
    J Am Coll Cardiol. 2016;68:999-1009.
    PubMed     Text format     Abstract available


    August 2016
  178. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    PubMed     Text format     Abstract available


  179. PICCOLO R, Eitel I, Galasso G, Dominguez-Rodriguez A, et al
    1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:727-38.
    PubMed     Text format     Abstract available


  180. GAUDINO M, Tondi P, Benedetto U, Milazzo V, et al
    Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results.
    J Am Coll Cardiol. 2016;68:603-10.
    PubMed     Text format     Abstract available


  181. ELGENDY IY, Mahmoud AN, Elgendy AY, Bavry AA, et al
    Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68:569-70.
    PubMed     Text format    


  182. RAISSADATI A, Nieminen H, Haukka J, Sairanen H, et al
    Late Causes of Death After Pediatric Cardiac Surgery: A 60-Year Population-Based Study.
    J Am Coll Cardiol. 2016;68:487-98.
    PubMed     Text format     Abstract available


    July 2016
  183. KHAN A, Gilani S, Dharmashankar K, Jaffery Z, et al
    Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement: Approach and Challenges.
    J Am Coll Cardiol. 2016;68:432-3.
    PubMed     Text format    


  184. HAWRANEK M, Wrobel M, Nozynski J, Pres D, et al
    Hemorrhagic Myocardial Infarction: Mortality Compared With STEMI Patients Treated With Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:426-7.
    PubMed     Text format    


  185. DIEGELER A
    Hybrid Coronary Revascularization: The Best of 2 Worlds?
    J Am Coll Cardiol. 2016;68:366-7.
    PubMed     Text format    


  186. PUSKAS JD, Halkos ME, DeRose JJ, Bagiella E, et al
    Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    J Am Coll Cardiol. 2016;68:356-65.
    PubMed     Text format     Abstract available


  187. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2016;68:29-36.
    PubMed     Text format     Abstract available


    May 2016
  188. MAHMUD E, Behnamfar O, Lin F, Reeves R, et al
    Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;67:2556-7.
    PubMed     Text format    


  189. STONE GW
    DAPT Duration After Coronary Stenting: Assessing Risk-Benefit Tradeoffs in Individual Patients.
    J Am Coll Cardiol. 2016;67:2503-5.
    PubMed     Text format    


    April 2016
  190. TANIGUCHI T, Morimoto T, Sakata R, Kimura T, et al
    Reply: Is it Time for a New Paradigm in Asymptomatic Severe Aortic Stenosis?: Asymptomatic Severe Aortic Stenosis: Oxymoron? A Randomized Trial in Patients With Asymptomatic Severe Aortic Stenosis: A Future Has Begun! Might Outcome of Patients With As
    J Am Coll Cardiol. 2016;67:1972-3.
    PubMed     Text format    


  191. BANOVIC M, Nikolic SD, Putnik S
    A Randomized Trial in Patients With Asymptomatic Severe Aortic Stenosis: A Future Has Begun!
    J Am Coll Cardiol. 2016;67:1970-1.
    PubMed     Text format    


  192. MARQUIS-GRAVEL G, Genereux P
    Asymptomatic Severe Aortic Stenosis: Oxymoron?
    J Am Coll Cardiol. 2016;67:1969-70.
    PubMed     Text format    


  193. SHERRID MV, Balaram S, Kim B, Axel L, et al
    The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context.
    J Am Coll Cardiol. 2016;67:1846-58.
    PubMed     Text format     Abstract available


  194. RODES-CABAU J, Hahn RT, Latib A, Laule M, et al
    Transcatheter Therapies for Treating Tricuspid Regurgitation.
    J Am Coll Cardiol. 2016;67:1829-45.
    PubMed     Text format     Abstract available


  195. GIRDAUSKAS E, Rouman M, Disha K, Fey B, et al
    Functional Aortic Root Parameters and Expression of Aortopathy in Bicuspid Versus Tricuspid Aortic Valve Stenosis.
    J Am Coll Cardiol. 2016;67:1786-96.
    PubMed     Text format     Abstract available


  196. ONORATI F, Dobson GP, San Biagio L, Abbasciano R, et al
    Superior Myocardial Protection Using "Polarizing" Adenosine, Lidocaine, and Mg2+ Cardioplegia in Humans.
    J Am Coll Cardiol. 2016;67:1751-3.
    PubMed     Text format    


  197. NEWBURGER JW, Takahashi M, Burns JC
    Kawasaki Disease.
    J Am Coll Cardiol. 2016;67:1738-49.
    PubMed     Text format     Abstract available


  198. VADUGANATHAN M, Bhatt DL, Cryer BL, Liu Y, et al
    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1661-71.
    PubMed     Text format     Abstract available


    March 2016
  199. TRANBAUGH RF, Schwann TA, Habib RH
    Reply: CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1504-5.
    PubMed     Text format    


  200. PHILIP F, Southard JA
    CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1503-4.
    PubMed     Text format    


  201. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502-3.
    PubMed     Text format    


  202. MCDANIEL M, Wenger N
    Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502.
    PubMed     Text format    


  203. BAVRY AA, Park K
    Drug-Eluting Stents: Capable of Saving Lives in Dialysis Patients?
    J Am Coll Cardiol. 2016;67:1470-1.
    PubMed     Text format    


  204. WEINTRAUB WS
    TAVR in Nonagenarians: Pushing the Boundaries.
    J Am Coll Cardiol. 2016;67:1396-8.
    PubMed     Text format    


  205. VAHL TP, Kodali SK, Leon MB
    Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure.
    J Am Coll Cardiol. 2016;67:1472-87.
    PubMed     Text format     Abstract available


  206. MARON MS, Rowin EJ, Olivotto I, Casey SA, et al
    Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:1399-409.
    PubMed     Text format     Abstract available


  207. ARSALAN M, Szerlip M, Vemulapalli S, Holper EM, et al
    Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry.
    J Am Coll Cardiol. 2016;67:1387-95.
    PubMed     Text format     Abstract available


  208. BARBANTI M, Tamburino C, D'Errigo P, Ranucci M, et al
    Reply: TAVI in Lower Risk Patients: Revolution or Nonsense? Keep Calm and Select Patients.
    J Am Coll Cardiol. 2016;67:1381-2.
    PubMed     Text format    


  209. SPADACCIO C, Fraldi M, Sablayrolles JL, Nappi F, et al
    TAVI in Lower Risk Patients: Revolution or Nonsense? Keep Calm and Select Patients.
    J Am Coll Cardiol. 2016;67:1380-1.
    PubMed     Text format    


  210. LOPES RD, Leonardi S, Neely B, Neely ML, et al
    Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
    J Am Coll Cardiol. 2016;67:1289-97.
    PubMed     Text format     Abstract available


  211. MARTIN RP
    Commercial Use of MVR: What Have We Learned and What Do We Need to Know?
    J Am Coll Cardiol. 2016;67:1141-4.
    PubMed     Text format    


  212. SORAJJA P, Mack M, Vemulapalli S, Holmes DR Jr, et al
    Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States.
    J Am Coll Cardiol. 2016;67:1129-40.
    PubMed     Text format     Abstract available


  213. BOKMA JP, Winter MM, Oosterhof T, Vliegen HW, et al
    Pulmonary Valve Replacement After Repair of Pulmonary Stenosis Compared With Tetralogy of Fallot.
    J Am Coll Cardiol. 2016;67:1123-4.
    PubMed     Text format    


  214. BARBANTI M
    TAVR and Left Main Stenting: Can 2 Giants Live in Harmony in a Small Room?
    J Am Coll Cardiol. 2016;67:961-2.
    PubMed     Text format    


  215. CHAKRAVARTY T, Sharma R, Abramowitz Y, Kapadia S, et al
    Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
    J Am Coll Cardiol. 2016;67:951-60.
    PubMed     Text format     Abstract available


    February 2016
  216. SCHOFER J, Tiburtius C, Hammerstingl C, Dickhaut PO, et al
    Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System.
    J Am Coll Cardiol. 2016;67:889-90.
    PubMed     Text format    


  217. MACK MJ, Douglas PS, Holmes DR
    Shedding More Light on Valve Thrombosis After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;67:656-8.
    PubMed     Text format    


  218. DEL TRIGO M, Munoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, et al
    Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After Transcatheter Aortic Valve Replacement: Multicenter Registry.
    J Am Coll Cardiol. 2016;67:644-55.
    PubMed     Text format     Abstract available


  219. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Survival Differences in Clinical Trials With Long-Term Follow-up.
    J Am Coll Cardiol. 2016;67:601.
    PubMed     Text format    


  220. KOSTIS WJ, Moreyra AE, Cabrera J, Kostis JB, et al
    Survival Differences in Clinical Trials With Long-Term Follow-Up.
    J Am Coll Cardiol. 2016;67:600.
    PubMed     Text format    


  221. BONOW RO, Adams DH
    The Time Has Come to Define Centers of Excellence in Mitral Valve Repair.
    J Am Coll Cardiol. 2016;67:499-501.
    PubMed     Text format    


  222. SURI RM, Clavel MA, Schaff HV, Michelena HI, et al
    Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes.
    J Am Coll Cardiol. 2016;67:488-98.
    PubMed     Text format     Abstract available


  223. YAKUBOV SJ
    Reply: When is TAVR in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery Appropriate?
    J Am Coll Cardiol. 2016;67:461.
    PubMed     Text format    


  224. PHILIP F
    When Is TAVR in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery Appropriate?
    J Am Coll Cardiol. 2016;67:460.
    PubMed     Text format    


    January 2016
  225. ALFONSO F, Perez Vizcayno MJ, Cardenas A, Garcia Del Blanco B, et al
    Reply: Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:348-9.
    PubMed     Text format    


  226. SCHELLER B, Ong PJ, Kleber F
    Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:346-7.
    PubMed     Text format    


  227. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  228. BODEN WE, Mancini GB
    CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?
    J Am Coll Cardiol. 2016;67:56-8.
    PubMed     Text format    


  229. MILOJEVIC M, Head SJ, Parasca CA, Serruys PW, et al
    Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX.
    J Am Coll Cardiol. 2016;67:42-55.
    PubMed     Text format     Abstract available


  230. DHRUVA SS, Krumholz HM
    The Core Value of Cost-Effectiveness Analyses.
    J Am Coll Cardiol. 2016;67:39-41.
    PubMed     Text format    


  231. REYNOLDS MR, Lei Y, Wang K, Chinnakondepalli K, et al
    Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;67:29-38.
    PubMed     Text format     Abstract available


  232. DEDIC A, Lubbers MM, Schaap J, Lammers J, et al
    Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study.
    J Am Coll Cardiol. 2016;67:16-26.
    PubMed     Text format     Abstract available


  233. STONE GW, Hochman JS, Williams DO, Boden WE, et al
    Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    J Am Coll Cardiol. 2016;67:81-99.
    PubMed     Text format     Abstract available


    December 2015
  234. ANYANWU AC, Adams DH
    Evaluating Catheter-Based Mitral Valve Therapies: Lessons Learned and Future Directions.
    J Am Coll Cardiol. 2015;66:2855-9.
    PubMed     Text format    


  235. FELDMAN T, Kar S, Elmariah S, Smart SC, et al
    Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.
    J Am Coll Cardiol. 2015;66:2844-54.
    PubMed     Text format     Abstract available


  236. ELEID MF, Pellikka PA
    Asymptomatic Severe Aortic Stenosis: What Are We Waiting For?
    J Am Coll Cardiol. 2015;66:2842-3.
    PubMed     Text format    


  237. BONOW RO
    Asymptomatic Aortic Stenosis: It Is Not Simple Anymore.
    J Am Coll Cardiol. 2015;66:2839-41.
    PubMed     Text format    


    October 2015
  238. DANGAS GD, Lefevre T, Kupatt C, Tchetche D, et al
    Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement. A Randomized Phase 3 Trial.
    J Am Coll Cardiol. 2015 Oct 8. pii: S0735-1097(15)06791.
    PubMed     Text format     Abstract available


  239. TANIGUCHI T, Morimoto T, Shiomi H, Ando K, et al
    Initial Surgical versus Conservative Strategies in Patients with Asymptomatic Severe Aortic Stenosis.
    J Am Coll Cardiol. 2015 Oct 6. pii: S0735-1097(15)06789.
    PubMed     Text format     Abstract available


    March 2015
  240. WEBBER SA, Hsu DT, Ivy DD, Kulik TJ, et al
    Task Force 7: Pediatric Cardiology Fellowship Training in Pulmonary Hypertension, Advanced Heart Failure, and Transplantation.
    J Am Coll Cardiol. 2015 Mar 9. pii: S0735-1097(15)00818.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: